3 ms·

There has to be a business model for passing these savings on to US consumers. It's much like the dilemma big publishers are facing: If you sell through the i

There has to be a business model for passing these savings on to US consumers. It's much like the dilemma big publishers are facing: If you sell through the internet from a country like India, shipping the drugs in anonymous packages, how is US law enforcement going to stop you without substantially infringing on other people's liberty?

mhb 17y ago
The "savings" are the difference between the cost of manufacturing drugs (negligible) versus amortizing the development and approval cost (enormous). Very smart people are already spending a lot of money and effort to reduce drug development cost. Reform the FDA to reduce approval cost. Mandate lower drug prices in some other way and say goodbye to future new drugs.
- ZeroGravitas 17y ago
  "Mandate lower drug prices in some other way and say goodbye to future new drugs." Or find new, different, better ways to promote and reward invention and say hello to lots more future drugs. Patents are broken, even if you agree with them in principle. See software patents for an area where they are broken beyond repair. Medical patents distort the market a great deal. See the comments on the original article for various dubious schemes that only make sense under the current patent regime.